IXC 10.5% 6.0¢ invex therapeutics ltd

I suspect that they'll need to some preclinical work (e.g.,...

  1. 387 Posts.
    lightbulb Created with Sketch. 47
    I suspect that they'll need to some preclinical work (e.g., mice/rats) to ensure that the drug lowers ICP in that second indication. But I agree, given that it has been shown to be safe and well tolerated in humans, they could probably advance to clinical trials very quickly. I guess that's the point - there isn't much additional work needed to increase the value proposition to potential investors.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.007(10.5%)
Mkt cap ! $4.509M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $3.264K 54.4K

Buyers (Bids)

No. Vol. Price($)
1 600 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 20000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.